Redox Signal 10 (9), 14911500
Your provider builds the protocol around what we are actually trying to move clinically, not a default dose
Frias JP, Deenadayalan S, Erichsen L (2023) Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
The low pH of vitamin C and strong acids can destabilise the peptide, and combining with retinoids in a single routine often produces unnecessary irritation
They said the first, BPC-157, was one of the more commonly used peptides